Cetyl glycol

CAS No. 6920-24-7

Cetyl glycol( NSC 71525 | NSC-71525 | NSC71525 )

Catalog No. M27263 CAS No. 6920-24-7

Cetyl glycol favors the decomposition of the metal-organic precursor, formation of an intermediate Co(2+)Fe(3+)-oleate complex, and the nucleation of nanoparticles at lower temperatures. Cetyl glycol is a reducing agent that can be used in cosmetics.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 49 In Stock
10MG 73 In Stock
25MG 124 In Stock
50MG 186 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Cetyl glycol
  • Note
    Research use only, not for human use.
  • Brief Description
    Cetyl glycol favors the decomposition of the metal-organic precursor, formation of an intermediate Co(2+)Fe(3+)-oleate complex, and the nucleation of nanoparticles at lower temperatures. Cetyl glycol is a reducing agent that can be used in cosmetics.
  • Description
    Cetyl glycol favors the decomposition of the metal-organic precursor, formation of an intermediate Co(2+)Fe(3+)-oleate complex, and the nucleation of nanoparticles at lower temperatures. Cetyl glycol is a reducing agent that can be used in cosmetics.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    NSC 71525 | NSC-71525 | NSC71525
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    6920-24-7
  • Formula Weight
    298.467
  • Molecular Formula
    C18H34O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCCCCCCCC1OC1CCCCCCCC(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Brogden RN, et al. Labetalol: a review of its pharmacology and therapeutic use in hypertension. Drugs. 1978;15(4):251-270.
molnova catalog
related products
  • Daratumumab

    Daratumumab is a human monoclonal antibody that targets CD38 a cell surface protein that is overexpressed on multiple myeloma MM) cells.

  • Saponarin

    Saponarin shows in vitro and in vivo hepatoprotective and antioxidant activity against CCl4-induced liver damage.

  • Brandioside

    Brandioside shows strong antioxidant, and neuroprotective effects, it significantly attenuates glutamate-induced neurotoxicity at concentrations ranging from 0.1 to 10 microM; it exhibits significant inhibition of advanced glycation end product formation with the IC50 value of 4.6-25.7 μM.